Screening for Risk Factors for the Development of Phlebitis After Intravenous Fluid Therapy in Children With <i>Mycoplasma pneumoniae</i> Pneumonia

To investigate the risk factors for the occurrence of phlebitis after intravenous infusion therapy in children with <i>Mycoplasma pneumoniae</i> pneumonia. A total of 108 children with <i>Mycoplasma pneumoniae</i> pneumonia who received intravenous infusion therapy from December 2020 to December 2023 in our hospital were retrospectively analyzed. In the phlebitis group, the proportion of children with maximum body temperature ≥39℃ before treatment, the proportion of children with fever duration ≥3 days, and the proportion of children with combined pleural effusion were significantly higher (<i>P</i> < .05). Higher inflammation level before the initiation of treatment, longer duration of fever, and unsuccessful intravenous treatment are all risk factors for the occurrence of phlebitis in children with <i>Mycoplasma pneumoniae</i> pneumonia. Attention should be paid to the management of the whole process of intravenous infusion to reduce the incidence of this complication.